Although the graphene sales are no where near where I expect, the developments Mike and the team have commenced are all progressing well.
It will be interesting to see how quickly these concrete developments move into commercial sales.
Cash burn is down to around $1mil per QTR with the company have enough funds for another 4.7 QTR
- Forums
- ASX - By Stock
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
Although the graphene sales are no where near where I expect,...
Featured News
Add FGR (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.5¢ |
Change
-0.003(7.89%) |
Mkt cap ! $23.44M |
Open | High | Low | Value | Volume |
3.8¢ | 3.8¢ | 3.2¢ | $11.67K | 326.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 478487 | 3.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.6¢ | 70330 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 478487 | 0.032 |
5 | 531300 | 0.030 |
1 | 25000 | 0.025 |
1 | 22394 | 0.023 |
1 | 118000 | 0.022 |
Price($) | Vol. | No. |
---|---|---|
0.036 | 70330 | 1 |
0.039 | 20000 | 1 |
0.040 | 275284 | 2 |
0.041 | 1860 | 1 |
0.043 | 122904 | 2 |
Last trade - 15.57pm 15/11/2024 (20 minute delay) ? |
Featured News
FGR (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online